What is the theory behind this therapy?

The theory is based on ultrasonic technology combined with traditional Chinese medicine principles.

Where is the nearest shipping port?

The nearest port is Guangzhou HuangPu.

Cart-Based Microwave Therapy Machine to Promote Blood Circulation

Name: Cart-Based Microwave Therapy Machine to Promote Blood Circulation
Brand: GUANGDONG HONGYANG MEDICAL EQUIPMENT LIMITED
SKU: 2051775165

Guangdong, ChinaGUANGDONG HONGYANG MEDICAL EQUIPMENT LIMITED

US$3,800.00-4,200.00

20 Pieces

Sample price:US$131.00/piece.Request sample

Product profile

Customization

Available

Type

Ultrasound Therapy

Function

Repair Tissue

Model NO.

MY-S008H-A

Theory

Ultrasonic

Certification

LCD Display

Without LCD Display

Group

Adult

Quality

High Quality

Transport Package

Paper

Specification

49*13*32

Trademark

MAYAMED

Origin

China

Key features

Multi-Function Therapy: Merges ultrasound, heat, and acupuncture point treatment for comprehensive care.

TCM Integration: Combines traditional Chinese medicine theory with modern science technology.

Pain Relief: Reduces sensory nerve excitability to achieve effective pain relief.

Blood Circulation: Improves partial blood circulation of body lesions and enhances metabolism.

Tissue Repair: Softens organization and strengthens drug permeability for tissue repair.

CE Certified: Product holds CE certification for safety and compliance.

High Quality: Manufactured with high quality standards for reliable performance.

Qi and Blood Balance: Follows meridians to balance Qi and blood and adjust yin and yang.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceCustomization from DesignsR&D Capabilities

GUANGDONG HONGYANG MEDICAL EQUIPMENT LIMITED

Guangdong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2021-09-10Nearest Port: Guangzhou HuangPuAverage Response Time: ≤5.51hTerms of Payment: T/T, PayPal, Western UnionInternational Commercial Terms(Incoterms): FOB, EXW, CFR, CIF

AI-Powered supplier vetting

SummaryThe supplier is identified as a Chinese limited company combining trading and manufacturing activities, with a valid import/export license and six employees. It reports certifications including QHSE, BSCI, ISO 14001, and ISO 9001. Product information indicates annual capacities of 1,000 anesthesia machines, 1,000 ventilators, and 5,000 vaporizers. The supplier supports multiple customization modes and reports exports to several African and Southeast Asian countries. It describes professional after-sales, installation, commissioning, and training services, with plans for more than 20 service points. Financial records are indicated for 2021–2023, but no substantive financial performance details are provided. Innovation resources appear limited by the absence of an SDK and only one stated R&D engineer, while quality-control test equipment is reported as zero.

Supplier typeThe supplier is described as a factory, trading company, and manufacturer/factory. It is a Chinese limited company located in Guangzhou, has six employees, and reports no associated company group or cooperative suppliers, indicating a small standalone operating structure.

CertificationsThe supplier reports holding QHSE, BSCI, ISO 14001, and ISO 9001 certifications. These explicitly stated certifications provide evidence of established management-system coverage, although the slices do not provide certificate scope or validity details.

After-Sales capabilityThe supplier states that it has a professional after-sales service team and installation technical engineer team, provides online and offline technical training plus installation and commissioning training, and aims to establish more than 20 service points in Africa, Southeast Asia, and the Middle East. These statements support an explicit after-sales and deployment capability.

R&D capabilityThe supplier reports one R&D engineer responsible for customer requirement confirmation, after-sales technical support, and new product development. It also explicitly reports no available SDK, while the stated total R&D engineer experience is 50 years; the limited headcount and absent SDK constrain the evidence of broader innovation capability.

Production capacityReported annual production is 1,000 anesthesia machines, 1,000 ventilators, and 5,000 vaporizers, with the same output information appearing in the production record. However, quality-control test equipment is reported as zero, which is an explicit production-quality infrastructure deficiency despite the stated capacity.

Customization capabilityThe supplier explicitly offers customization from samples, designs, full customization, minor customization, and flexible customization. Its company description also states that equipment and software can be customized according to customer needs, providing direct evidence of broad customization support.